ClinicalTrials.gov
ClinicalTrials.gov Menu

Dexmedetomidine vs. Remifentanil for Sedation During AFI

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00349245
Recruitment Status : Completed
First Posted : July 6, 2006
Last Update Posted : March 23, 2016
Sponsor:
Collaborator:
Hospira, now a wholly owned subsidiary of Pfizer
Information provided by (Responsible Party):
Carin A. Hagberg, The University of Texas Health Science Center, Houston

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2007
  Actual Study Completion Date : August 2007